Board of Directors

  • cgoddard

  • Colin Goddard, Ph.D.
    Chairman & CEO

    Colin Goddard is an investor in the company and has been part of the leadership team since the inception of BlinkBio in 2015.  Dr. Goddard was formerly CEO of OSI Pharmaceuticals for 12 years, raising over $1.5 billion and overseeing the development, launch and commercialization of the lung cancer drug Tarceva through to OSI’s $4 billion acquisition by Astellas.  He also Chairs the board of Mission Therapeutics and is a board member of the drug conjugate company Endocyte (NASDAQ:ECYT).  Dr.Goddard obtained his PhD in cancer chemotherapy in the UK and completed post-doctoral training at the National Cancer Institute in Bethesda, MD.

     

  • gsmith

  • Geoff Smith

    Geoffrey W. Smith is a co-founder and General Partner of Ascent Biomedical Ventures, a venture capital fund focused on early-stage life sciences investments. He currently represents Ascent on the Board of Directors for Azevan Pharmaceuticals, BackBeat Medical, BlinkBio, and Caliber Therapeutics, and is a Board Observer of Vivasure Medical. Geoff is also the founder and Managing Partner of Digitalis Ventures. He currently represents Digitalis as a Director of CareDox and GRO Biosciences, and as a Board Observer of Second Genome. Geoff received a B.A. (with honors) from Williams College and a J.D. from the University of Pennsylvania Law School.

  • mgargano

  • Michael Gargano

    Michael Gargano joined the BlinkBio board in 2009 as a founder of the Company and continues to serve as the representative of the Series A investors. Michael is a Managing Director at Argent Ventures LLC, where he is responsible for structuring and financing new acquisitions and for overseeing development, leasing and management of the firm’s properties. Prior to joining Argent, Mr. Gargano was a real estate attorney with the law firm of Shearman & Sterling, where he represented institutional and government clients on major real estate development and financing transactions. He is Chairman of the Board of iCareDx, a diagnostics company. He is a member of the Board of Directors of the Fund for Public Health – NY, the Hollywood Chamber of Commerce and the Hollywood Property Owners Alliance. Mr. Gargano earned a B.A. from the State University of New York at Stony Brook and a J.D. from Boston University.

  • vmehta

     

  • Viren Mehta, PharmD, MBA

    Viren Mehta founded and is managing member of Mehta Partners, LLC. His analytical insights on global health care have influenced bio-pharmaceutical strategy and investments worldwide. Educated at the University of Southern California (Doctor of Pharmacy) and UCLA (MBA in international finance and marketing), he has worked with senior BioPharma leaders and investment managers for over 30 years. Viren’s biopharma strategic advisory work focuses on refining the business model to expand global healthcare access, and to help the bio-pharmaceutical industry succeed globally. Viren’s philanthropic work in ecology and education through viram foundation includes an active board role with Project Hope (Washington DC) and the Venice Family Clinic (Los Angeles, CA). Viren began with Merck & Co. in international strategic planning and competitor analysis. This foundation prompted Wood MacKenzie & Company Inc. to invite him to establish a pharmaceutical research function in New York. This effort was expanded at S.G. Warburg & Company, and led to the formation of the BioPharma investment advisory group Mehta and Isaly. Now known as Mehta Partners, with a 30-year record, Viren continues to focus on helping refine investment strategy to achieve superior growth while enhancing access to healthcare innovations.